UTRS (Minerva Surgical) Stock Based Compensation: $5.01 Mil (TTM As of Sep. 2023)


What is Minerva Surgical Stock Based Compensation?

Minerva Surgical UTRS -99.00% Stock Based Compensation is $5.01 Mil as of Sep. 2023.

Minerva Surgical's Stock Based Compensation for the three months ended in Sep. 2023 was $0.83 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 was $5.01 Mil.

Minerva Surgical Stock Based Compensation Related Terms

Minerva Surgical Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Minerva Surgical's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical Stock Based Compensation Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Stock Based Compensation
0.59 0.86 6.82 6.98

Minerva Surgical Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.98 1.80 1.27 1.10 0.83

Minerva Surgical Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.01 Mil.

What does a Stock Based Compensation of $5.01 Mil mean?
Minerva Surgical (UTRS) has a Stock Based Compensation of $5.01 Mil as of Sep. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Minerva Surgical and its competitors.
Is Minerva Surgical's Stock Based Compensation too high?
Minerva Surgical's current Stock Based Compensation is $5.01 Mil.
How does Minerva Surgical's Stock Based Compensation compare to PAVM and ELUT?
Minerva Surgical's Stock Based Compensation of $5.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Minerva Surgical and its competitors. Minerva Surgical's current Stock Based Compensation is $5.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Surgical stock overvalued right now?
Minerva Surgical (UTRS) has a current Stock Based Compensation of $5.01 Mil. The current Stock Based Compensation is $5.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Minerva Surgical (UTRS), the current Stock Based Compensation is $5.01 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Surgical Business Description

Address 4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.